Literature DB >> 17362669

Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?

Jaswinder K Sethi1.   

Abstract

Adipokines are peptides secreted by adipose tissue that affect whole-body energy metabolism. Their dysregulated production in obesity has implicated them as important mediators in the pathogenesis of obesity-related risk factors for diabetes and cardiovascular disease. PBEF/visfatin/Nampt has recently been described as a novel adipokine with insulin mimetic properties. However, whether it is an authentic adipokine relevant to the metabolic syndrome remains a matter of some debate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362669      PMCID: PMC4301309          DOI: 10.1007/s11906-007-0007-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  45 in total

1.  Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.

Authors:  K C Choi; O H Ryu; K W Lee; H Y Kim; J A Seo; S G Kim; N H Kim; D S Choi; S H Baik; K M Choi
Journal:  Biochem Biophys Res Commun       Date:  2005-10-28       Impact factor: 3.575

2.  Structure of the insulin receptor ectodomain reveals a folded-over conformation.

Authors:  Neil M McKern; Michael C Lawrence; Victor A Streltsov; Mei-Zhen Lou; Timothy E Adams; George O Lovrecz; Thomas C Elleman; Kim M Richards; John D Bentley; Patricia A Pilling; Peter A Hoyne; Kellie A Cartledge; Tam M Pham; Jennifer L Lewis; Sonia E Sankovich; Violet Stoichevska; Elizabeth Da Silva; Christine P Robinson; Maurice J Frenkel; Lindsay G Sparrow; Ross T Fernley; V Chandana Epa; Colin W Ward
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

3.  Increased visfatin concentrations in women with gestational diabetes mellitus.

Authors:  Katarzyna Krzyzanowska; Walter Krugluger; Friedrich Mittermayer; Rupa Rahman; Dominik Haider; Nadja Shnawa; Guntram Schernthaner
Journal:  Clin Sci (Lond)       Date:  2006-05       Impact factor: 6.124

4.  Free fatty acids normalize a rosiglitazone-induced visfatin release.

Authors:  Dominik G Haider; Friedrich Mittermayer; Georg Schaller; Michaela Artwohl; Sabina M Baumgartner-Parzer; Gerhard Prager; Michael Roden; Michael Wolzt
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-05-30       Impact factor: 4.310

5.  Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.

Authors:  Tao Wang; Xiangbin Zhang; Poonam Bheda; Javier R Revollo; Shin-ichiro Imai; Cynthia Wolberger
Journal:  Nat Struct Mol Biol       Date:  2006-06-18       Impact factor: 15.369

6.  Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes.

Authors:  Susan Kralisch; Johannes Klein; Ulrike Lossner; Matthias Bluher; Ralf Paschke; Michael Stumvoll; Mathias Fasshauer
Journal:  J Endocrinol       Date:  2005-06       Impact factor: 4.286

7.  Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes.

Authors:  Susan Kralisch; Johannes Klein; Ulrike Lossner; Matthias Bluher; Ralf Paschke; Michael Stumvoll; Mathias Fasshauer
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-05-17       Impact factor: 4.310

8.  A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization.

Authors:  S E Hufton; P T Moerkerk; R Brandwijk; A P de Bruïne; J W Arends; H R Hoogenboom
Journal:  FEBS Lett       Date:  1999-12-10       Impact factor: 4.124

9.  Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.

Authors:  Miao-Pei Chen; Fu-Mei Chung; Dao-Ming Chang; Jack C-R Tsai; Han-Fen Huang; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  J Clin Endocrinol Metab       Date:  2005-10-18       Impact factor: 5.958

10.  Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer.

Authors:  Judy R Van Beijnum; Peter T M Moerkerk; Andrea J Gerbers; Adriaan P De Bruïne; Jan-Willem Arends; Hennie R Hoogenboom; Simon E Hufton
Journal:  Int J Cancer       Date:  2002-09-10       Impact factor: 7.396

View more
  19 in total

1.  Membrane raft-lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin.

Authors:  Min Xia; Chun Zhang; Krishna M Boini; Audrey M Thacker; Pin-Lan Li
Journal:  Cardiovasc Res       Date:  2010-09-07       Impact factor: 10.787

2.  Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme.

Authors:  Javier R Revollo; Antje Körner; Kathryn F Mills; Akiko Satoh; Tao Wang; Antje Garten; Biplab Dasgupta; Yo Sasaki; Cynthia Wolberger; R Reid Townsend; Jeffrey Milbrandt; Wieland Kiess; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2007-11       Impact factor: 27.287

Review 3.  Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.

Authors:  Shin-Ichiro Imai
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 4.  Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.

Authors:  John N Fain
Journal:  Mediators Inflamm       Date:  2010-05-23       Impact factor: 4.711

Review 5.  From heterochromatin islands to the NAD World: a hierarchical view of aging through the functions of mammalian Sirt1 and systemic NAD biosynthesis.

Authors:  Shin-ichiro Imai
Journal:  Biochim Biophys Acta       Date:  2009-03-13

6.  Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

Review 7.  TNF-alpha and adipocyte biology.

Authors:  William P Cawthorn; Jaswinder K Sethi
Journal:  FEBS Lett       Date:  2007-11-26       Impact factor: 4.124

8.  Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Francesca Gotsch; Pooja Mittal; Nandor Gabor Than; Chia-Lang Nhan-Chang; Neil Hamill; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Samuel S Edwin; Jyh Kae Nien; Ricardo Gomez; Jimmy Espinoza; Claire Kendal-Wright; Sonia S Hassan; Gillian Bryant-Greenwood
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

Review 9.  Nampt: linking NAD biology, metabolism and cancer.

Authors:  Antje Garten; Stefanie Petzold; Antje Körner; Shin-Ichiro Imai; Wieland Kiess
Journal:  Trends Endocrinol Metab       Date:  2008-12-26       Impact factor: 12.015

Review 10.  The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importance.

Authors:  Shin-Ichiro Imai
Journal:  Cell Biochem Biophys       Date:  2009       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.